Podda M, Roncalli M, Battezzati P M, Borzio M, Bruno S, Servida E, Coggi G
Istituti di Medicina, Università di Milano, Italy.
Ital J Gastroenterol. 1992 Jan;24(1):39-42.
Liver-cell dysplasia is a well known histological entity with preneoplastic significance in experimental hepatic carcinogenesis. However, while the association of liver-cell dysplasia with hepatitis B virus can be considered as established, it is still controversial whether this lesion represents a premalignant condition in cirrhotic patients. Efforts have been made to render its morphological assessment more reliable, but no firm conclusions can be drawn from the available clinical studies, which are mainly retrospective or based on autopsy series. Preliminary results from a prospective study argue that liver-cell dysplasia is associated with an increased risk to hepatocellular carcinoma. The emergence of liver-cell dysplasia as a preneoplastic lesion in cirrhotic patients will have some impact in the future on their management, including selection for closer monitoring in early detection of hepatocellular carcinoma and for liver transplantation.
肝细胞发育异常是实验性肝癌发生过程中一种具有癌前病变意义的著名组织学实体。然而,虽然肝细胞发育异常与乙型肝炎病毒的关联可以被认为是确定的,但这种病变在肝硬化患者中是否代表癌前状态仍存在争议。人们已努力使肝细胞发育异常的形态学评估更可靠,但从现有的临床研究中无法得出确凿结论,这些研究主要是回顾性的或基于尸检系列。一项前瞻性研究的初步结果表明,肝细胞发育异常与肝细胞癌风险增加有关。肝细胞发育异常作为肝硬化患者的一种癌前病变的出现,未来将对其管理产生一些影响,包括在肝细胞癌早期检测和肝移植中选择更密切的监测。